Tissue resident C reactive protein in degenerative aortic valves: Correlation with serum C reactive protein concentrations and modification by statins

Heart

Volumn 92, Issue 4, 2006, Pages 495-498

  Skowasch, Dirk ^a   Schrempf, S ^a   Preusse, C J ^a   Likungu, J A ^a   Welz, A ^a   Luderitz B ^a   Bauriedel, G ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN;

AGED; AORTA STENOSIS; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; CORRELATION ANALYSIS; DRUG EFFECT; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PLEIOTROPY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TISSUE DEGENERATION;

AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; C-REACTIVE PROTEIN; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 33645213891     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.069815     Document Type: Article

References (31)

1. Carabello BA, Crawford FA Jr. Valvular heart disease. N Engl J Med 1997;337:32-41.
2. Chan KL. Is aortic stenosis a preventable disease? J Am Coll Cardiol 2003;42:593-9.
3. Farzaneh-Far A, Proudfoot D, Shanahan C, et al. Vascular and valvar calcification: recent advances. Heart 2001;85:13-7.
4. Mazzone A, Epistolato MC, De Caterina R, et al. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. J Am Coll Cardiol 2004;43:1670-6.
5. Mohler ER III, Gannon F, Reynolds C, et al. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522-8.
6. Rajamannan NM, Subramaniam M, Rickad D, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003;107:2181-4.
7. Ollson M, Dalsgard G, Haegerstrand A, et al. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994;23:1162-70.
8. Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesions of 'degenerative' valvular aortic stenosis: Histologic and immunohistochemical studies. Circulation 1994;90:844-54.
9. Satta J, Melkko J, Pöllännen R, et al. Progression of human aortic valve stenosis is associated with tenascin-C expression. J Am Coll Cardiol 2002;39:96-101.
10. Skowasch D, Yeghiazaryan K, Schrempf S, et al. Persistence of Chlamydia pneumoniae in degenerative aortic valve stenosis indicated by heat shock protein 60 homologues. J Heart Valve Dis 2003;12:68-75. t
11. Koden JJ, Dempfle CE, Grobholz R, et al. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis 2003;170:205-1 1.
12. Kuusisto J, Rösänen K, Särkioja T, et al. Atherosclerosis-like lesions of the aortic valve are common in adults of all stages: a necropsy study. Heart 2005;91:576-82.
13. Skowasch D, Jabs A, Andrié R, et al. Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis: tissue characteristics compared to primary atherosclerosis. J Vasc Res 2004;41:525-34.
14. Galante A, Pietroiusti A, Vellini M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001;38:1078-82.
15. Gerber IL, Stewart RA, Hammett G, et al. Effect of aortic valve replacement on C-reactive protein in nonrheumatic aortic stenosis. Am J Cardiol 2003;92:1129-32.
16. Aronow WS, Ahn C, Kronzon I, et al. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001;88:693-5.
17. Novaro GM, Tiong IY, Pearce GL, et al. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001;104:2205-9.
18. Bellamy MF, Pellikka PA, Klarich KW, et al. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002;40:1723-30.
19. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin- converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004;110:1291-5.
20. Bauriedel G, Jabs A, Skowasch D, et al. Dendritic cells in neointima formation after rat carotid balloon injury: coordinated expression with anti-apoptotic Bcl-2 and HSP47 in arterial repair. J Am Coll Cardiol 2003;42:930-8.
21. Burke AP, Tracy RP, Kolodgie F, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002;105:2019-23.
22. Yasojima K, Schwab C, McGeer EG, et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001;158:1039-51.
23. Vainas T, Lubbers T, Stassen FR, et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 2003;107:1103-5.
24. Jabs WJ, Theissing E, Nitschke M, et al. Local generation of C-reactive protein in diseased artery venous bypass grafts and normal vascular tissue. Circulation 2003;108:1428-31.
25. Skowasch D, Jabs, A, Andrié R, et al. Progression of native coronary plaques and in-stent restenosis are associated and predicted by increased preprocedural C reactive protein. Heart 2005;91:535-6.
26. Pasceri V, Cheng J, Willerson JT, et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001;103:2531-4.
27. Torzewski M, Rist C, Mortensen RF, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Tnromb Vasc Biol 2000;20:2094-9.
28. Calabro P, Willerson JT, Yeh ETH. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003;108:1930-2.
29. Paul A, Ko KWS, Li L, et al. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004;109:647-55.
30. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005;352:20-8.
31. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2441-3.